Aessoa Ultra

AESSOA ULTRA

For clinics comparing closely related products, AESSOA ULTRA stands out through the connection between cross-linked hyaluronic acid and deeper-fold correction, facial contour definition, and volume restoration. Its more structural profile is most relevant when the treatment plan involves chin, cheeks and midface, and jawline or masseter area.

The Product in Practice

A closer look at AESSOA ULTRA shows a product built around practical choices: what it contains, the type of correction it supports and how it differs from adjacent variants.

• AESSOA ULTRA formulation: cross-linked hyaluronic acid, hyaluronic acid, and lidocaine
• AESSOA ULTRA: Main professional objectives: deeper-fold correction, facial contour definition, and volume restoration
• Areas most relevant to AESSOA ULTRA: chin, cheeks and midface, and jawline or masseter area
• Presentation details: 24mg/ml

Together, these details give AESSOA ULTRA a specific place in the catalogue and make comparison with neighbouring versions more useful.

1. Filler and Gel Profile

AESSOA ULTRA is positioned as a higher-structure profile associated with projection, contour support and volume restoration. The relationship between its formulation, strength, presentation and professional objective defines this exact product more clearly than its category name alone.

2. How the Gel Supports Correction

AESSOA ULTRA is designed to provide physical support within professionally selected tissue planes. Its practical behaviour is linked to the gel profile: softer variants favour integration and refinement, while more structured variants are selected when projection, contour definition or volume replacement is the priority. This variant is positioned toward the structural end of that range.

3. Main Correction Goals

• Facial contour refinement
• Volume restoration
• Structural projection
• Deep-fold correction
• Localized contour support

4. Facial Areas Suited to This Profile

AESSOA ULTRA is commonly associated with:

• Jawline and masseter area
• Chin
• Cheeks and midface
• Nasolabial folds
• Marionette lines

For AESSOA ULTRA, area selection, quantity and technique remain part of the practitioner’s product-specific plan.

5. Formulation and Syringe Specifications

The formulation includes cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride. The sealed label for AESSOA ULTRA remains the controlling reference for its exact ingredient statement.

• Product: AESSOA ULTRA
• Product type: Professional injectable dermal filler
• AESSOA ULTRA: Variant profile: A higher-structure profile associated with projection, contour support and volume restoration
• Reported strength or volume: 24 mg/ml, 1.0 ml, and 24mg/ml
• AESSOA ULTRA: Reported formulation: cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride
• Package details: 1.0 ml
• Origin: South Korea
• AESSOA ULTRA: Storage profile: do not freeze, protect from direct light, and room-temperature storage is mentioned

6. Expected Integration and Result Profile

For AESSOA ULTRA, for this presentation, the visible profile is linked to the selected correction goal. Integration, projection and contour support should be assessed according to the named gel variant, treatment plane, area and quantity used rather than applying one duration claim to the entire product family.

7. Package and Storage Information

For the named variant, the reported package presentation includes 1.0 ml. The available product information specifies do not freeze, protect from direct light, and room-temperature storage is mentioned. The sealed outer box and current instructions remain the controlling handling reference.

8. Fine, Deep or Volume: Where This Variant Fits

the product should be compared with neighbouring variants by gel profile, not simply by brand name. Fine or Soft versions generally favour delicate refinement; Deep or Mid versions provide more support for folds and contour; Volume, Implant or Sub-Q versions sit toward structural correction and projection. the named variant is positioned as a higher-structure profile associated with projection, contour support and volume restoration.

9. Frequently Asked Questions

What is AESSOA ULTRA?

For AESSOA ULTRA, the named variant is a professional injectable dermal filler positioned as a higher-structure profile associated with projection, contour support and volume restoration. Its page is built around the exact formulation and presentation rather than a generic description of the category.

What is the main purpose of AESSOA ULTRA?

For AESSOA ULTRA, for the named variant, its product profile centres on facial contour refinement, volume restoration, structural projection, and deep-fold correction. The final treatment objective and technique are selected by a qualified professional.

What does AESSOA ULTRA contain?

For AESSOA ULTRA, for this presentation, available product information describes cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride.

Which areas are associated with AESSOA ULTRA?

For AESSOA ULTRA, the product information associates this formulation with jawline and masseter area, chin, cheeks and midface, nasolabial folds, and marionette lines. Suitability and placement depend on the exact product instructions and individual assessment.

How is AESSOA ULTRA supplied?

the named variant is described with 1.0 ml. Current outer-box information remains the controlling reference for the received market presentation.

What makes this exact version different?

For AESSOA ULTRA, the named variant should be compared with neighbouring variants by gel profile, not simply by brand name. Fine or Soft versions generally favour delicate refinement; Deep or Mid versions provide more support for folds and contour; Volume, Implant or Sub-Q versions sit toward structural correction and projection. the named variant is positioned as a higher-structure profile associated with projection, contour support and volume restoration.